Where CRI Funds

Our scientists are making breakthrough discoveries at premier institutions around the world.

Let's spread the word about Immunotherapy! Click to share this page with your community.

Copy Link

Filter By:

*Immunotherapy results may vary from patient to patient.

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.

Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an impressive total of $110,000.